Brun-Heath Isabelle, Lia-Baldini Anne-Sophie, Maillard Stéphane, Taillandier Agnès, Utsch Boris, Nunes Mark E, Serre Jean-Louis, Mornet Etienne
Equipe Structure-Fonction et Génétique, EA 2493, CHU Paris Ile de France Ouest, Université de Versailles-Saint Quentin en Yvelines, France.
Eur J Med Genet. 2007 Sep-Oct;50(5):367-78. doi: 10.1016/j.ejmg.2007.06.005. Epub 2007 Jul 21.
Hypophosphatasia is a rare genetic disease characterized by diminished bone and tooth mineralization due to deficient activity of tissue-nonspecific alkaline phosphatase (TNSALP). The disease is clinically heterogeneous due to different mutations in the TNSALP gene. In order to determine whether mutated TNSALP proteins may be sequestered, degraded, or subjected to delay in their transport to the cell membrane, we built a plasmid expressing a YFP-TNSALP fluorescent fusion protein allowing the observation of cellular localization in live cells by fluorescence confocal microscopy at different time points after transfection. We studied five mutants (c. 571G>A, c. 653T>C, c. 746G>T, c. 1363G>A and c. 1468A>T) exhibiting various levels of in vitro residual enzymatic activity. While the wild-type protein reached the membrane within the first 24h after transfection, the mutants reached the membrane with delays of 24, 48 or 72 h. For all of the tested mutations, accumulation of the mutated proteins, mainly in the Golgi apparatus, was observed. We concluded that reduced ALP activity of these TNSALP mutants results from structural disturbances and delay in membrane anchoring, and not from compromised catalytic activity.
低磷酸酯酶症是一种罕见的遗传性疾病,其特征是由于组织非特异性碱性磷酸酶(TNSALP)活性不足导致骨骼和牙齿矿化减少。由于TNSALP基因的不同突变,该疾病在临床上具有异质性。为了确定突变的TNSALP蛋白是否可能被隔离、降解或在转运到细胞膜的过程中延迟,我们构建了一个表达YFP-TNSALP荧光融合蛋白的质粒,通过转染后不同时间点的荧光共聚焦显微镜观察活细胞中的细胞定位。我们研究了五个表现出不同水平体外残余酶活性的突变体(c. 571G>A、c. 653T>C、c. 746G>T、c. 1363G>A和c. 1468A>T)。野生型蛋白在转染后的最初24小时内到达细胞膜,而突变体到达细胞膜的时间延迟了24、48或72小时。对于所有测试的突变,均观察到突变蛋白的积累,主要在高尔基体中。我们得出结论,这些TNSALP突变体的碱性磷酸酶活性降低是由于结构紊乱和膜锚定延迟,而不是催化活性受损。